Eran Broshy - Insider Trading & Ownership

Location
C/O Ventiv Health, 200 Cottontail Ln. Vantage Court N., Somerset, NJ
Summary
The estimated net worth of Eran Broshy is at least $2.91M dollars as of November 14, 2025. Eran Broshy is the Director of Theravance Biopharma, Inc. and owns shares of Theravance Biopharma, Inc. (TBPH) stock worth about $2.21M. Eran Broshy is the Director, Chairman of Certara, Inc. and owns shares of Certara, Inc. (CERT) stock worth about $697K.
Signature
/s/ Brett Grimaud, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Eran Broshy

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TBPH Theravance Biopharma, Inc. Director $2.21M -$809K -26.8% Nov 11, 2025
CERT Certara, Inc. Director, Chairman $697K May 21, 2025

Insider Transactions Reported by Eran Broshy:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.